Medication info

Darim Atorvastatin 40 mg Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletExpired
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Darim Biotech Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 120 tablets/bottle
Approval status
Expired

MFDS item code 201903323 · Approved 2019.05.22

This product's status changed to Expired on 2024.05.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults
Adult dosage
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient’s characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Ingredients

Manufacturer
Darim Biotech Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • revascularization procedure
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abetalipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It decreases the risk of myocardial infarction and stroke and has preventive effects against revascularization procedures and angina. It shows positive effects, particularly in adults with multiple risk factors and patients with type 2 diabetes. Additionally, it is used to lower cholesterol and triglyceride levels in patients with primary hyperlipidemia and dyslipidemia while increasing HDL, the good cholesterol. It can also be utilized when dietary adjustments are not sufficient, improving cardiovascular health through lipid regulation. Overall, it is effectively used in the treatment of heart disease and hyperlipidemia.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient’s characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This drug is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Precautions

This medication may result in muscle-related side effects, so if there are symptoms such as muscle pain or weakness, discontinue use immediately and consult a doctor. This medication can affect liver function, so it should not be used in patients with liver disease or elevated liver enzyme levels, and regular liver function tests should be conducted. Pregnant women, women who may become pregnant, and breastfeeding women should not take this medication, and women of childbearing age should practice appropriate contraception while on this medication. Children, especially those under 10 years old, should not use this medication, and long-term safety in individuals under 18 years has not been established. Older adults or patients with impaired kidney function should be closely monitored for the risk of muscle abnormalities and rhabdomyolysis while taking this medication. This medication can interact with various drugs; therefore, it is crucial to inform your doctor or pharmacist about any other medications you are taking, especially when used in conjunction with specific antibiotics, antifungals, antivirals, or some hyperlipidemia medications. No specific antidote is available for overdose; treatment should be symptomatic, with monitoring of liver function and muscle damage. This medication should be stored out of reach of children and not transferred to a different container from its original packaging. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, inform healthcare personnel immediately and get tested. Additionally, avoid consuming grapefruit juice while on this medication, as it may increase blood levels and the risk of side effects.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 159 more
  • loss of appetite
  • constipation
  • abdominal distention
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vasculitis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • thrombocytopenia
  • positive urinary leukocytes
  • increased serum CK
  • abnormal liver function tests
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • erectile dysfunction
  • urinary tract infection
  • increased urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • respiratory distress
  • asthma
  • dizziness
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • tension headache
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia
  • contracture
  • elevated CK
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • sweating
  • urticaria
  • eczema
  • seborrhea
  • skin ulcer
  • itching
  • rash
  • alopecia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container, protected from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius to preserve its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 120 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.